Viewing Study NCT00988156

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:33 PM
Ignite Modification Date: 2026-02-19 @ 11:42 PM
Study NCT ID: NCT00988156
Status: COMPLETED
Last Update Posted: 2018-11-13
First Post: 2009-10-01
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children
Sponsor: Bial - Portela C S.A.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Partial Epilepsy in Children and Adolescents View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Epilepsy View
None Partial View
None Refractory View
None Children View
None Adolescents View
None Adjunctive View
None Randomised View
None Double-blind View
None Placebo-controlled View
None Parallel-group View